Characteristic | Enrolled in studya(n = 107) | Declined to participatea(n = 12) |
---|---|---|
Opioid treatment program (enrollment site) | Â | Â |
   1 | 39 (36) | 2 (17) |
   2 | 35 (33) | 1 (8) |
   3 | 8 (8) | 0 |
   4 | 14 (13) | 9 (75) |
   5 | 11 (10) | 0 |
Female | 51 (48) | 7 (58) |
Race | Â | Â |
   African American | 88 (82) | 7 (58) |
   Caucasian/other | 19 (18) | 5 (42) |
Age, years | 47 (41-51) | 46 (38-51) |
Education | Â | Â |
   Less than high school graduate | 51 (48) |  |
   High school graduate or equivalent | 36 (34) |  |
   Any college, n (%) | 20 (19) |  |
Marital status | Â | Â |
   Married or live with partner | 17 (16) |  |
   Never married | 54 (51) |  |
   Widowed | 9 (8) |  |
   Divorced or separated | 27 (25) |  |
Considers himself/herself to be homeless | 32 (30) | Â |
Housing/living situation | Â | Â |
   Own a house | 3 (3) |  |
   Rent an apartment/house | 49 (46) |  |
   Stay with family or friends | 35 (33) |  |
   Residential drug treatment | 5 (5) |  |
   Other residential facility or institution | 11 (10) |  |
   Live on street or in single room occupancy hotel | 4 (4) |  |
Employed | 16 (15) | Â |
Duration of methadone or buprenorphine treatment, months | 11 (2-49) | Â |
Receiving methadone | 99 (93) | Â |
   Methadone dose, mg | 90 (70-120) |  |
Receiving buprenorphine | 8 (7) | Â |
   Buprenorphine dose, mg | 19 (14-27) |  |
Depression scoreb | 11 (5-15) | Â |
Urine drug test, positive results | Â | Â |
   Cocaine | 42 (40)c |  |
   Benzodiazepine | 14 (13)c |  |
   Opiate (morphine/codeine) | 21 (20)c |  |
   Oxycodone | 1 (1)c |  |
Nadir CD4 count, cells/mm3 | 102 (30-218) | Â |
Current CD4 count, cells/mm3 | 182 (69-309) | Â |
HIV RNA log10 copies/mL | 4.7 (4.0-5.1) | Â |
Hospitalized in prior 3 months | 34 (32) | Â |
Prior AIDS-defining opportunistic condition | 66 (62) | Â |
Hepatitis C antibody positive | 87 (81) | Â |
Antiretroviral naive | 21 (20) | Â |
Category of prescribed antiretroviral regimen | Â | Â |
   PI + NRTIs | 83 (78) |  |
   NNRTI + NRTIs | 16 (15) |  |
   NRTIs only | 1 (1) |  |
   Other | 7 (7) |  |
Drug classes included in antiretroviral regimen (not mutually exclusive) | Â | Â |
   NRTI | 97 (91) |  |
   Ritonavir-boosted PI | 85 (79) |  |
   PI (not boosted with ritonavir) | 4 (4) |  |
   NNRTI | 21 (20) |  |
   Integrase inhibitor | 7 (7) |  |
Dosing frequency of prescribed antiretroviral regimen | Â | Â |
   Once daily | 65 (61) |  |
   Twice daily | 42 (39) |  |